Press Releases

TissueTech, Inc. Awarded Patent for Compositions of Morselized Umbilical Cord and Amniotic Membrane

MIAMI – May 14, 2018 – TissueTech Inc., the pioneer in the development and clinical application of regenerative amniotic tissue-based products, announced that it has been awarded patent 9,808,491 by the U.S. Patent Trademark Office. The patent applies to the use of a gel composition comprising morselized placental amniotic membrane and/or morselized umbilical cord. as […]


TissueTech Appoints Dr. Frank Young Executive Vice President of Regulatory Affairs

MIAMI, FL – May 10, 2018 – TissueTech Inc., pioneers of the development and clinical application of amniotic tissue-based products, announced today the appointment of Dr. Frank Young as Executive Vice President of Regulatory Affairs. “Dr. Young’s appointment continues TissueTech’s tradition as a leader in innovation and quality,” said Amy Tseng, Chief Executive Officer of […]


Clinical Evidence Presented at SAWC on Application of Amniox Medical Products

MIAMI, FL – May 8, 2018 – Amniox Medical, Inc., a TissueTech, Inc. company, highlighted four clinical posters demonstrating the effectiveness of NEOX® Wound Allograft at the Symposium on Advanced Wound Care (SAWC) in April.


Amniox Medical Awarded Premier Agreement for Regenerative Medicine Products Offers Access to Amniotic Membrane Products to Premier Members

ATLANTA, GA – December 11, 2017 – Amniox Medical, Inc., a TissueTech, Inc. company, has been awarded a group purchasing agreement for Regenerative Skin Grafting Products with Premier. Effective January 1, 2018, the new agreement allows Premier members, at their discretion, to take advantage of special terms pre-negotiated by Premier for the full Amniox Medical […]


Amniox Medical Awarded Premier Agreement for Regenerative Medicine Products

ATLANTA, GA – December 11, 2017 – Amniox Medical, Inc., a TissueTech, Inc. company, has been awarded a group purchasing agreement for Regenerative Skin Grafting Products with Premier. Effective January 1, 2018, the new agreement allows Premier members, at their discretion, to take advantage of special terms pre-negotiated by Premier for the full Amniox Medical […]


Amniox Medical Introduces RESPINA™ at NASS 2017

RESPINA umbilical cord/amniotic membrane matrix for microdiscectomy earns 2017 Spine Technology Award ORLANDO – October 26, 2017 – Amniox Medical, Inc., a TissueTech, Inc. company, highlighted the introduction of RESPINA its cryopreserved umbilical cord/amniotic membrane matrix at the North American Spine Society’s (NASS) annual meeting in Orlando, FL, October 25 – 27. Amniox Medical’s proprietary […]


TissueTech Inc. Awarded Four Patents for Proprietary Technology to Use Placental Tissue for Regenerative Medicine

Company has more than 40 issued patents MIAMI – September 14, 2017 – TissueTech Inc. announced today that it has been awarded four patents by the U.S. Patent Trademark Office. Two of the patents cover methods of promoting bone formation and the others cover methods for lyophilizing and sterilizing placental tissue. “TissueTech continues to maintain […]


TissueTech, Inc. Names John Arnott, Industry Executive, to Board of Directors

Arnott brings experience in a wide range of global healthcare businesses MIAMI – August 3, 2017 – TissueTech Inc. announced today that it has named John Arnott to its Board of Directors. Mr. Arnott was most recently Operating Partner and Executive Chairman of multiple portfolio companies for The Riverside Company, one of largest and oldest […]


TissueTech, Inc. Names Dr. Herbert B. Slade as Chief Medical Officer

MIAMI – August 1, 2017 – TissueTech, Inc. announced today that Herbert B. Slade, MD, has been named the company’s Chief Medical Officer (CMO). Dr. Slade, who will lead the execution of TissueTech’s clinical research strategies and be the primary liaison for medical affairs, has more than 25 years of healthcare industry-based experience, most recently […]


Study Demonstrating Improved Outcomes in Pain Reduction and Function for Discectomy Patients with CLARIX® 100 Highlighted in Medical Journal

Proprietary technology demonstrates significant improvement in short-term and long-term outcomes ATLANTA – July 10, 2017 – Amniox Medical, Inc., a TissueTechTM, Inc. company, announced today that the results of a clinical study on the efficacy of CLARIX Cryopreserved Amniotic Membrane in lumbar microdiscectomy surgery was published in the May 2017 online issue of Clinical Spine […]